Abstract: The present invention relates to an in vitro method for evaluating the prognosis of an autoimmune or chronic inflammatory disease in an individual, comprising the following steps: a) determining (i) the level of an anti-IL-17 autoantibody and/or (ii) the level of an [IL-17/anti-IL-17 autoantibody] complex in a biological sample of the individual, and b) comparing the level of autoantibody and/or of complex determined in step a) with a reference value, the comparison being indicative of the prognosis of an autoimmune or chronic inflammatory disease in said individual.
Type:
Grant
Filed:
April 24, 2017
Date of Patent:
July 4, 2023
Assignees:
Hospices Civil de Lyon, Universite Claude Bernard Lyon 1, Eurobio Scientific
Inventors:
Pierre Miossec, Ndieme Thiam, Jean-Jacques Pin